Grant: Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Université Laval
$100,000.00
Engineering, Cloning, Expression and Small Scale Purification of St1Cas9 and variants in Escherichia coli
FY 2020-21 · 2020-09-17
Summary
This Project seeks to produce recombinant St1Cas9 and variants and test their efficiency both in vitro and in vivo. These recombinant gene editing tools will become part of the toolkit the NRC-CGT Program aims to build to facilitate multiplex combinatorial gene editing in induced pluripotent stem cells (iPSCs) and immune cells. Along with the production of SpCas9, MAD7, and potentially Cas12a, the production of St1Cas9 and variants will broaden target flexibility and help to accelerate innovation and discovery cycles in engineered cell and gene therapies.
Department
Program
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Recipient
Location
Quebec|Québec, Quebec, Canada
Recipient Type
Academia
Business Number
119278950
Type
Grant
Source
Proactive Disclosure - Grants and Contributions
As published
Agreement End Date
2022-09-17
Agreement Number
956909
Agreement Start Date
2020-09-17
Agreement Title
Engineering, Cloning, Expression and Small Scale Purification of St1Cas9 and variants in Escherichia coli
Agreement Title (French)
Ingénierie, clonage, expression et purification à petite échelle de souches de St1Cas9 et de ses variantes dans Escherichia coli
Agreement Type
Grant
Agreement Value
$100,000.00
Amendment Number
0
Description
This Project seeks to produce recombinant St1Cas9 and variants and test their efficiency both in vitro and in vivo. These recombinant gene editing tools will become part of the toolkit the NRC-CGT Program aims to build to facilitate multiplex combinatorial gene editing in induced pluripotent stem cells (iPSCs) and immune cells. Along with the production of SpCas9, MAD7, and potentially Cas12a, the production of St1Cas9 and variants will broaden target flexibility and help to accelerate innovation and discovery cycles in engineered cell and gene therapies.
Description (French)
Ce projet vise à produire des souches de St1Cas9 recombinantes et de souches variantes et à tester leur efficacité in vitro et in vivo. Ces outils d’édition de gènes recombinants feront partie de la trousse que le programme des technologies de rupture au service des thérapies cellulaires et géniques du CNRC vise à créer pour faciliter l’édition multiplex de gènes combinatoires dans les cellules souches pluripotentes induites (iPSC) et les cellules immunitaires. Parallèlement à la production de souches de SpCas9, de MAD7 et potentiellement de Cas12a, la production de souches de St1Cas9 et de souches variantes élargira la flexibilité des cibles et elle contribuera à accélérer les cycles d’innovation et de découverte dans le domaine des thérapies cellulaires et géniques.
Expected Results
In the short term, anticipated outcomes will be strengthened collaborations across industry, academia, and government to support research excellence. In the medium term, anticipated outcomes will be the development of new and potentially disruptive technologies with collaborators. In the long term, find collaborative solutions to public policy challenges and create stronger innovation systems.
Expected Results (French)
À court terme, les résultats prévus seront des collaborations renforcées entre l'industrie, le milieu universitaire et le gouvernement pour soutenir l'excellence en recherche. À moyen terme, les résultats attendus seront le développement de nouvelles technologies potentiellement perturbatrices avec des collaborateurs. À long terme, trouver des solutions collaboratives aux défis des politiques publiques et créer des systèmes d'innovation plus solides.
Federal Riding
Louis-Hébert
Federal Riding (French)
Louis-Hébert
Federal Riding Number
24044
NAICS Code
541710
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Collaborative Science, Technology and Innovation Program - Collaborative R&D Initiatives
Program Name (French)
Programme de collaboration en science, en technologie et en innovation - Initiatives de collaboration en R-D
Program Purpose
Collaborate on multiparty research and development programs to catalyze transformative, high-risk, high-reward research with the potential for game-changing scientific discoveries and technological breakthroughs in priority areas.
Program Purpose (French)
Collaborer à des programmes multipartites de recherche-développement dans le but de profiter de la synergie entre la recherche transformatrice à haut risque et à haut rendement et le potentiel de découvertes scientifiques et de percées technologiques révolutionnaires dans des secteurs d’intervention prioritaires.
Recipient Business Number
119278950
Recipient City
Quebec|Québec
Recipient Country
CA
Recipient Legal Name
Université Laval
Recipient Postal Code
G1V 0A6
Recipient Province or Territory
QC
Recipient Type
S
Reference Number
172-2020-2021-Q2-956909